COVID-19 Emerging themes: T-cell immune responses & immunoSEQ T-MAP COVID applications

At the beginning of 2020, few would have predicted that a global pandemic would turn our daily lives upside down. But a year later, the research community may have a clearer view of what might lie ahead. Throughout 2020, Adaptive Biotechnologies, along with researchers and collaborators around the world, contributed to the massive effort to understand and fight the COVID-19 pandemic. This webinar focuses on what we have learned so far, and emerging research terms for COVID-19.

In this webinar, we discuss:

  • new research data and insights into T-cell immune response signal, including disease severity, neutralizing antibody response, and research data on vaccine vs. viral response;
  • the new immunoSEQ® T-MAP™ COVID feature, called the Classifier, how it was developed, what this feature can tell you, and how can it be used to propel your COVID-19 research;
  • the current and future research applications of the immunoSEQ T-MAP COVID tools;
  • future research directions and implications of the T-cell immune response for fighting emerging SARS-CoV-2 variants.

For Research Use Only. Not for use in diagnostic procedures.


Thomas Snyder PhD

VP, Research
Adaptive Biotechnologies
Paul Fields, PhD, Manager, Computational Biology, Adaptive Biotechnologies

Paul Fields PhD

Manager, Computational Biology,
Adaptive Biotechnologies

Register for SEQdiscovery

To access these videos and all SEQdiscovery content.
If you have previously registered and opted to have an account please log in above.